Home > Insider Trading > Filing (0001883850-23-000031)

Filing Details

Accession Number:: 0001883850-23-000031
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-02-03 16:15:24
Reporting Period:: 2023-02-01

Accepted Time:: 2023-02-03 16:15:24
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
872589	Regeneron Pharmaceuticals Inc.	REGN	Pharmaceutical Preparations (2834)	133444607

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1187443	F Arthur Ryan	777 Old Saw Mill River Road Tarrytown NY 10591		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2023-02-01	2	$752.11	19,345	No	4	S	Direct
Common Stock	Disposition	2023-02-01	18	$753.54	19,327	No	4	S	Direct
Common Stock	Disposition	2023-02-01	17	$754.45	19,310	No	4	S	Direct
Common Stock	Disposition	2023-02-01	17	$755.50	19,293	No	4	S	Direct
Common Stock	Disposition	2023-02-01	24	$756.77	19,269	No	4	S	Direct
Common Stock	Disposition	2023-02-01	2	$757.29	19,267	No	4	S	Direct
Common Stock	Disposition	2023-02-01	7	$758.58	19,260	No	4	S	Direct
Common Stock	Disposition	2023-02-01	4	$759.65	19,256	No	4	S	Direct
Common Stock	Disposition	2023-02-01	4	$760.40	19,252	No	4	S	Direct
Common Stock	Disposition	2023-02-01	3	$761.58	19,249	No	4	S	Direct
Common Stock	Disposition	2023-02-01	2	$762.17	19,247	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 2 shares of Company stock on February 1, 2023 at prices ranging from $752.02 to $752.19. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.
Represents volume-weighted average price of sales of 18 shares of Company stock on February 1, 2023 at prices ranging from $753.05 to $753.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.
Represents volume-weighted average price of sales of 17 shares of Company stock on February 1, 2023 at prices ranging from $754.08 to $754.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.
Represents volume-weighted average price of sales of 17 shares of Company stock on February 1, 2023 at prices ranging from $755.11 to $755.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.
Represents volume-weighted average price of sales of 24 shares of Company stock on February 1, 2023 at prices ranging from $756.18 to $756.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.
Represents volume-weighted average price of sales of 2 shares of Company stock on February 1, 2023 at prices ranging from $757.02 to $757.56. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.
Represents volume-weighted average price of sales of 7 shares of Company stock on February 1, 2023 at prices ranging from $758.29 to $758.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.
Represents volume-weighted average price of sales of 4 shares of Company stock on February 1, 2023 at prices ranging from $759.30 to $759.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.
Represents volume-weighted average price of sales of 4 shares of Company stock on February 1, 2023 at prices ranging from $760.09 to $760.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.
Represents volume-weighted average price of sales of 3 shares of Company stock on February 1, 2023 at prices ranging from $761.49 to $761.62. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.
Represents volume-weighted average price of sales of 2 shares of Company stock on February 1, 2023 at prices ranging from $762.15 to $762.19. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2023 at each separate price.